Startseite Performance characteristics of a microfluidic Lab-on-Chip electrophoresis system for high-density lipoprotein (HDL) subfraction separation and measurement
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Performance characteristics of a microfluidic Lab-on-Chip electrophoresis system for high-density lipoprotein (HDL) subfraction separation and measurement

  • Dan-Hui D. Yang , Yves Konigshofer , Jude Dike , Elaine Chang und Odilo Mueller
Veröffentlicht/Copyright: 19. März 2010
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: High-density lipoprotein (HDL) is believed to be protective against coronary heart disease (CHD). HDL is comprised of different subfractions. Of these, HDL 2b is believed to be the most important in preventing CHD. Current methods for HDL subfraction measurements are not standardized and often exhibit poor analytical performance, which can limit their usefulness in clinical practice.

Methods: We have developed a microfluidic Lab-on-Chip electrophoresis system for serum HDL subfraction measurements. Linear polymers are used as a sieving buffer for HDL particle separation. Nine samples and two controls can be analyzed in 30 min. The percent HDL 2b that comprises total high-density lipoprotein cholesterol (HDL-C) is reported.

Results: Samples with HDL-C of 0.259–2.072 mmol/L could be evaluated for percent HDL 2b with coefficient of variations (%CVs) below 8%. Total precision was typically below 1.5% and linearity was observed between 8% and 32% HDL 2b. Measurements were not affected by many therapeutic and biological compounds. Consistent results were obtained by three laboratories and showed r2 values between 0.93 and 0.95.

Conclusions: The assay allows for easy and reproducible measurement of percent HDL 2b. The experimental procedure and small size of the instrumentation needed for measurement make it viable in clinical settings.

Clin Chem Lab Med 2010;48:883–9.


Corresponding author: Dan-Hui D. Yang, Agilent Technologies, Inc., 5301 Stevens Creek Blvd., 3U-WG, Santa Clara, CA 95051, USA Fax: +1-408-553-7100,

Received: 2009-10-27
Accepted: 2010-1-8
Published Online: 2010-03-19
Published in Print: 2010-06-01

©2010 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editorials
  2. The “Obamanomics”: a revolution in laboratory diagnostics
  3. Skeletal muscle biomarkers: not new but still interesting diagnostic tools
  4. Necessity for high-quality reference materials in the harmonization of laboratory assays
  5. Reviews
  6. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features
  7. Biochemical markers of muscular damage
  8. Minireview
  9. Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory?
  10. Guidelines and Recommendations
  11. 2010 Consensus statement on the worldwide standardization of the hemoglobin A1c measurement
  12. Genetics and Molecular Diagnostics
  13. Development of a low-cost real-time reverse transcriptase-polymerase chain reaction technique for the detection and quantification of hepatitis C viral load
  14. Microsatellite polymorphisms in intron 2 of the toll-like receptor 2 gene and their association with susceptibility to pulmonary tuberculosis in Han Chinese
  15. Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy
  16. General Clinical Chemistry and Laboratory Medicine
  17. Traceability of values for catalytic activity concentration of enzymes: a Certified Reference Material for aspartate transaminase
  18. Development and preparation of a new serum protein reference material: feasibility studies and processing
  19. A WHO Reference Reagent for the Serum Transferrin Receptor (sTfR): international collaborative study to evaluate a recombinant soluble transferrin receptor preparation
  20. Hyperhomocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis
  21. Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios
  22. New quantitative electrochemiluminescence method (ECLIA) for interleukin-6 (IL-6) measurement
  23. Evaluation of cell counting and leukocyte differentiation in cerebrospinal fluid controls using hematology analyzers by the German Society for Clinical Chemistry and Laboratory Medicine
  24. Reference Values and Biological Variations
  25. The relationship of coffee and green tea consumption with high-sensitivity C-reactive protein in Japanese men and women
  26. Cancer Diagnostics
  27. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
  28. Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer
  29. Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population
  30. Cardiovascular Diseases
  31. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome
  32. Performance characteristics of a microfluidic Lab-on-Chip electrophoresis system for high-density lipoprotein (HDL) subfraction separation and measurement
  33. Letters to the Editor
  34. Hemolysis correction factor in the measurement of serum neuron-specific enolase
  35. Serum paraoxonase-1 activity and genetic polymorphisms: common errors in measurement and interpretation of results
  36. Neuropharmacology of schizophrenia: is there a role for leptin?
  37. Relationship between serum concentrations of keratin-18 and apoptosis in chronic hepatitis C
Heruntergeladen am 6.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.133/html?lang=de
Button zum nach oben scrollen